Fengli Li

Featured in: Favicon

jamanetwork.com Favicon

onlinelibrary.wiley.com Favicon

pubs.acs.org Favicon

jnis.bmj.com Favicon

Articles

Adjunctive Intra-arterial Urokinase after Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Stroke (POST-UK): Study protocol of a multicenter, prospective, randomized, open-label, blinded-endpoint trial

Aug 6, 2024 | medrxiv.org | Chang Liu |Fengli Li |Jiaxing Song |Xu Xu

JLS reports consulting fees for advising on rigorous and safe clinical trial design and conduct from Biogen, Boehringer Ingelheim, Genentech, Johnson&Johnson, Phenox, Phillips, Rapid Medical, and Roche. There are no competing interests for the other authors. ChiCTR2200065617 (www.chictr.org.cn).
Readers of RNA Modification in Cancer and Their Anticancer Inhibitors

Jul 22, 2024 | mdpi.com | Fengli Li |Wenjin Li

This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessReview by Fengli Li Fengli Li Scilit Preprints.org Google Scholar and Wenjin Li Wenjin Li Scilit Preprints.org Google Scholar * Institute for Advanced Study, Shenzhen University, Shenzhen 518060, China *Author to whom correspondence should be addressed.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →